Guggenheim Capital LLC Illumina, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 66,385 shares of ILMN stock, worth $9.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

66,385

Previous 69,848 4.96%

Holding current value

$9.07 Million

Previous $7.29 Million 18.74%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$105.28 - $135.9 $364,584 - $470,621	-3,463 Reduced 4.96%	66,385 $8.66 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $62,347 - $82,412	-617 Reduced 0.88%	69,848 $7.29 Million
Q1 2024 May 14, 2024	BUY	$127.73 - $147.2 $55,690 - $64,179	436 Added 0.62%	70,465 $9.68 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $612,785 - $941,268	6,604 Added 10.41%	70,029 $9.75 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $924,671 - $1.38 Million	7,173 Added 12.75%	63,425 $8.71 Million
Q2 2023 Aug 11, 2023	BUY	$183.43 - $232.67 $530,112 - $672,416	2,890 Added 5.42%	56,252 $10.5 Million
Q1 2023 May 10, 2023	SELL	$193.75 - $232.55 $57,543 - $69,067	-297 Reduced 0.55%	53,362 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $64,036 - $83,017	342 Added 0.64%	53,659 $10.8 Million
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $362,080 - $464,659	-2,043 Reduced 3.69%	53,317 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $47,392 - $96,048	261 Added 0.47%	55,360 $10.2 Million
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $4.27 Million - $5.96 Million	-14,067 Reduced 20.34%	55,099 $19.3 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $2.36 Million - $2.87 Million	6,798 Added 10.9%	69,166 $26.3 Million
Q3 2021 Nov 15, 2021	SELL	$405.61 - $524.84 $723,608 - $936,314	-1,784 Reduced 2.78%	62,368 $25.3 Million
Q2 2021 Aug 13, 2021	SELL	$372.84 - $481.5 $816,146 - $1.05 Million	-2,189 Reduced 3.3%	64,152 $30.4 Million
Q1 2021 May 13, 2021	SELL	$361.28 - $504.76 $7.85 Million - $11 Million	-21,722 Reduced 24.67%	66,341 $25.5 Million
Q4 2020 Feb 16, 2021	SELL	$292.7 - $370.96 $1.15 Million - $1.45 Million	-3,918 Reduced 4.26%	88,063 $32.6 Million
Q3 2020 Nov 13, 2020	SELL	$268.51 - $400.74 $1.64 Million - $2.44 Million	-6,097 Reduced 6.22%	91,981 $28.4 Million
Q2 2020 Aug 14, 2020	BUY	$256.46 - $373.01 $2.36 Million - $3.44 Million	9,209 Added 10.36%	98,078 $36.3 Million
Q1 2020 Jun 02, 2020	SELL	$209.2 - $335.53 $4.16 Million - $6.68 Million	-19,898 Reduced 18.29%	88,869 $24.3 Million
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $4.79 Million - $5.58 Million	16,626 Added 18.04%	108,767 $36.1 Million
Q3 2019 Nov 14, 2019	BUY	$266.84 - $378.23 $379,980 - $538,599	1,424 Added 1.57%	92,141 $28 Million
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $1.12 Million - $1.38 Million	-3,739 Reduced 3.96%	90,717 $33.4 Million
Q1 2019 May 15, 2019	BUY	$272.57 - $321.18 $3.42 Million - $4.03 Million	12,553 Added 15.33%	94,456 $29.3 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $8.62 Million - $11.6 Million	-31,637 Reduced 27.86%	81,903 $24.6 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $1.31 Million - $1.73 Million	4,702 Added 4.32%	113,540 $41.7 Million
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $63.7 Million - $81.6 Million	-279,277 Reduced 71.96%	108,838 $30.4 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $6.97 Million - $8.44 Million	-33,246 Reduced 7.89%	388,115 $91.8 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $25 Million - $28.4 Million	123,555 Added 41.49%	421,361 $92.1 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $51.3 Million - $63.7 Million	297,806	297,806 $59.3 Million

Others Institutions Holding ILMN

# of Institutions

898

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Illumina, Inc. Transaction History